Featured Research
Lowering Dosage of Retinopathy Injection Treatment Did Not Decrease Effectiveness Intravitreous bevacizumab has become an increasingly common way to treat retinopathy of prematurity (ROP) in infants, but systemic toxicity remains one of its potentially dangerous side effects.
Read Featured Research